Evo Fund short positions
Current short positions and disclosure history reported by this institution.
Stocks held (0.5% or more)
0 stocks
15 stocks reported
Total position (shares)
0
Total of current positions
Last report
2026-02-09
Latest calculation date
Number of Stocks Held Last 5 years, weekly, positions of 0.5% or more
Number of stocks in which this institution reports a short position of 0.5% or more. Hover over (or tap) the chart to see the weekly count and total shares.
Current Positions Latest report for each stock
| Last report | Stock | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2018-12-12 | LEGAL CORPORATION3497 | Position 11,800 shares | Ratio 0.41% | ▼0.17% | Below 0.5% |
| 2018-02-07 | ARDEPRO Co.,Ltd.8925 | Position 1,120,500 shares | Ratio 0.40% | ▼0.11% | Below 0.5% |
| 2020-01-15 | FRUTA FRUTA INC.2586 | Position 0 shares | Ratio 0.00% | ▼17.70% | Closed |
| 2025-06-24 | Metaplanet Inc.3350 | Position 0 shares | Ratio 0.00% | ▼4.99% | Closed |
| 2020-12-25 | FUJITA CORPORATION Co.,Ltd.3370 | Position 0 shares | Ratio 0.00% | ▼0.91% | Closed |
| 2025-12-26 | AltPlusInc.3672 | Position 0 shares | Ratio 0.00% | ▼0.69% | Closed |
| 2025-06-05 | Remixpoint,inc.3825 | Position 0 shares | Ratio 0.00% | ▼1.47% | Closed |
| 2024-04-19 | SymBio Pharmaceuticals Limited4582 | Position 0 shares | Ratio 0.00% | ▼1.73% | Closed |
| 2025-08-12 | RIBOMIC Inc.4591 | Position 0 shares | Ratio 0.00% | ▼4.48% | Closed |
| 2025-09-11 | Def consulting,inc.4833 | Position 0 shares | Ratio 0.00% | ▼8.02% | Closed |
| 2026-02-09 | W-SCOPE Corporation6619 | Position 0 shares | Ratio 0.00% | ▼2.24% | Closed |
| 2020-01-30 | PIXELA CORPORATION6731 | Position 0 shares | Ratio 0.00% | ▼1.44% | Closed |
| 2021-04-09 | The Lead Co.,Inc.6982 | Position 0 shares | Ratio 0.00% | ▼0.65% | Closed |
| 2025-08-25 | MAC HOUSE CO.,LTD.7603 | Position 0 shares | Ratio 0.00% | ▼9.91% | Closed |
| 2020-05-15 | Kozosushi Co.,LTD.9973 | Position 0 shares | Ratio 0.00% | ▼1.65% | Closed |
Disclosure History Latest 100
| Trade date | Stock | Position (shares) | Ratio | Change | Short seller |
|---|---|---|---|---|---|
| 2026-02-09 | W-SCOPE Corporation6619 | Position 0 shares | Ratio 0.00% | ▼2.24% | Evo Fund |
| 2026-02-06 | W-SCOPE Corporation6619 | Position 1,290,000 shares | Ratio 2.24% | ▲0.40% | Evo Fund |
| 2026-02-05 | W-SCOPE Corporation6619 | Position 1,060,000 shares | Ratio 1.84% | ▲0.70% | Evo Fund |
| 2026-02-04 | W-SCOPE Corporation6619 | Position 655,000 shares | Ratio 1.14% | ▲0.47% | Evo Fund |
| 2026-02-03 | W-SCOPE Corporation6619 | Position 386,100 shares | Ratio 0.67% | ▲0.67% | Evo Fund |
| 2025-12-26 | AltPlusInc.3672 | Position 0 shares | Ratio 0.00% | ▼0.69% | Evo Fund |
| 2025-11-27 | AltPlusInc.3672 | Position 467,100 shares | Ratio 0.69% | ▲0.69% | Evo Fund |
| 2025-09-11 | Def consulting,inc.4833 | Position 0 shares | Ratio 0.00% | ▼8.02% | Evo Fund |
| 2025-09-04 | Def consulting,inc.4833 | Position 2,889,000 shares | Ratio 8.02% | ▲0.69% | Evo Fund |
| 2025-09-03 | Def consulting,inc.4833 | Position 2,635,000 shares | Ratio 7.33% | ▲0.58% | Evo Fund |
| 2025-09-02 | Def consulting,inc.4833 | Position 2,410,000 shares | Ratio 6.75% | ▲0.55% | Evo Fund |
| 2025-09-01 | Def consulting,inc.4833 | Position 2,215,000 shares | Ratio 6.20% | ▲1.52% | Evo Fund |
| 2025-08-29 | Def consulting,inc.4833 | Position 1,670,000 shares | Ratio 4.68% | ▲1.11% | Evo Fund |
| 2025-08-28 | Def consulting,inc.4833 | Position 1,274,100 shares | Ratio 3.57% | ▲3.15% | Evo Fund |
| 2025-08-25 | MAC HOUSE CO.,LTD.7603 | Position 0 shares | Ratio 0.00% | ▼9.91% | Evo Fund |
| 2025-08-22 | MAC HOUSE CO.,LTD.7603 | Position 2,240,000 shares | Ratio 9.91% | ▲1.21% | Evo Fund |
| 2025-08-21 | MAC HOUSE CO.,LTD.7603 | Position 1,965,600 shares | Ratio 8.70% | ▲1.31% | Evo Fund |
| 2025-08-20 | MAC HOUSE CO.,LTD.7603 | Position 1,670,000 shares | Ratio 7.39% | ▲5.04% | Evo Fund |
| 2025-08-19 | MAC HOUSE CO.,LTD.7603 | Position 531,800 shares | Ratio 2.35% | ▲1.79% | Evo Fund |
| 2025-08-18 | MAC HOUSE CO.,LTD.7603 | Position 126,000 shares | Ratio 0.56% | ▲0.56% | Evo Fund |
| 2025-08-12 | RIBOMIC Inc.4591 | Position 0 shares | Ratio 0.00% | ▼4.48% | Evo Fund |
| 2025-08-08 | RIBOMIC Inc.4591 | Position 2,000,500 shares | Ratio 4.48% | ▲3.43% | Evo Fund |
| 2025-08-07 | RIBOMIC Inc.4591 | Position 468,000 shares | Ratio 1.05% | ▲1.05% | Evo Fund |
| 2025-06-24 | Metaplanet Inc.3350 | Position 0 shares | Ratio 0.00% | ▼4.99% | Evo Fund |
| 2025-06-17 | Metaplanet Inc.3350 | Position 30,000,000 shares | Ratio 4.99% | ▲0.65% | Evo Fund |
| 2025-06-11 | Metaplanet Inc.3350 | Position 26,042,500 shares | Ratio 4.34% | ▲0.59% | Evo Fund |
| 2025-06-10 | Metaplanet Inc.3350 | Position 22,512,700 shares | Ratio 3.75% | ▲1.53% | Evo Fund |
| 2025-06-09 | Metaplanet Inc.3350 | Position 13,334,600 shares | Ratio 2.22% | ▲2.22% | Evo Fund |
| 2025-06-05 | Remixpoint,inc.3825 | Position 0 shares | Ratio 0.00% | ▼1.47% | Evo Fund |
| 2025-06-04 | Remixpoint,inc.3825 | Position 1,844,500 shares | Ratio 1.47% | ▲0.66% | Evo Fund |
| 2025-05-27 | Remixpoint,inc.3825 | Position 1,010,600 shares | Ratio 0.81% | ▲0.32% | Evo Fund |
| 2024-12-17 | Metaplanet Inc.3350 | Position 0 shares | Ratio 0.00% | ▼4.02% | Evo Fund |
| 2024-12-13 | Metaplanet Inc.3350 | Position 1,456,200 shares | Ratio 4.02% | ▲1.62% | Evo Fund |
| 2024-12-12 | Metaplanet Inc.3350 | Position 871,497 shares | Ratio 2.40% | ▲2.40% | Evo Fund |
| 2024-04-19 | SymBio Pharmaceuticals Limited4582 | Position 0 shares | Ratio 0.00% | ▼1.73% | Evo Fund |
| 2024-04-10 | SymBio Pharmaceuticals Limited4582 | Position 775,100 shares | Ratio 1.73% | ▲0.11% | Evo Fund |
| 2024-04-01 | SymBio Pharmaceuticals Limited4582 | Position 725,200 shares | Ratio 1.62% | ▲0.14% | Evo Fund |
| 2024-03-29 | SymBio Pharmaceuticals Limited4582 | Position 664,100 shares | Ratio 1.48% | ▲0.22% | Evo Fund |
| 2024-03-28 | SymBio Pharmaceuticals Limited4582 | Position 563,000 shares | Ratio 1.26% | ▲0.18% | Evo Fund |
| 2024-03-27 | SymBio Pharmaceuticals Limited4582 | Position 482,400 shares | Ratio 1.08% | ▲0.19% | Evo Fund |
| 2024-03-26 | SymBio Pharmaceuticals Limited4582 | Position 399,600 shares | Ratio 0.89% | ▲0.13% | Evo Fund |
| 2024-03-25 | SymBio Pharmaceuticals Limited4582 | Position 340,100 shares | Ratio 0.76% | ▲0.25% | Evo Fund |
| 2024-03-21 | SymBio Pharmaceuticals Limited4582 | Position 227,100 shares | Ratio 0.51% | ▲0.51% | Evo Fund |
| 2024-02-29 | SymBio Pharmaceuticals Limited4582 | Position 0 shares | Ratio 0.00% | ▼3.05% | Evo Fund |
| 2024-02-26 | SymBio Pharmaceuticals Limited4582 | Position 962,900 shares | Ratio 2.21% | ▲0.38% | Evo Fund |
| 2024-02-22 | SymBio Pharmaceuticals Limited4582 | Position 796,300 shares | Ratio 1.83% | ▲0.09% | Evo Fund |
| 2024-02-21 | SymBio Pharmaceuticals Limited4582 | Position 755,500 shares | Ratio 1.74% | ▲0.36% | Evo Fund |
| 2024-02-20 | SymBio Pharmaceuticals Limited4582 | Position 599,000 shares | Ratio 1.38% | ▲0.33% | Evo Fund |
| 2024-02-19 | SymBio Pharmaceuticals Limited4582 | Position 458,300 shares | Ratio 1.05% | ▲0.22% | Evo Fund |
| 2024-02-16 | SymBio Pharmaceuticals Limited4582 | Position 360,000 shares | Ratio 0.83% | ▲0.30% | Evo Fund |
| 2024-02-15 | SymBio Pharmaceuticals Limited4582 | Position 230,000 shares | Ratio 0.53% | ▲0.28% | Evo Fund |
| 2024-02-07 | SymBio Pharmaceuticals Limited4582 | Position 0 shares | Ratio 0.00% | ▼2.83% | Evo Fund |
| 2024-02-01 | SymBio Pharmaceuticals Limited4582 | Position 1,197,000 shares | Ratio 2.83% | ▲0.12% | Evo Fund |
| 2024-01-26 | SymBio Pharmaceuticals Limited4582 | Position 1,144,000 shares | Ratio 2.71% | ▲0.08% | Evo Fund |
| 2024-01-25 | SymBio Pharmaceuticals Limited4582 | Position 1,110,000 shares | Ratio 2.63% | ▲0.04% | Evo Fund |
| 2024-01-24 | SymBio Pharmaceuticals Limited4582 | Position 1,097,000 shares | Ratio 2.59% | ▲0.16% | Evo Fund |
| 2024-01-19 | SymBio Pharmaceuticals Limited4582 | Position 1,025,900 shares | Ratio 2.43% | ▲0.06% | Evo Fund |
| 2024-01-18 | SymBio Pharmaceuticals Limited4582 | Position 1,002,100 shares | Ratio 2.37% | ▲0.25% | Evo Fund |
| 2024-01-17 | SymBio Pharmaceuticals Limited4582 | Position 896,500 shares | Ratio 2.12% | ▲0.21% | Evo Fund |
| 2024-01-16 | SymBio Pharmaceuticals Limited4582 | Position 806,700 shares | Ratio 1.91% | ▲0.26% | Evo Fund |
| 2024-01-15 | SymBio Pharmaceuticals Limited4582 | Position 698,700 shares | Ratio 1.65% | ▲0.31% | Evo Fund |
| 2024-01-12 | SymBio Pharmaceuticals Limited4582 | Position 565,800 shares | Ratio 1.34% | ▲0.33% | Evo Fund |
| 2024-01-11 | SymBio Pharmaceuticals Limited4582 | Position 427,300 shares | Ratio 1.01% | ▲0.14% | Evo Fund |
| 2024-01-10 | SymBio Pharmaceuticals Limited4582 | Position 368,200 shares | Ratio 0.87% | ▲0.87% | Evo Fund |
| 2023-12-22 | SymBio Pharmaceuticals Limited4582 | Position 0 shares | Ratio 0.00% | ▼2.92% | Evo Fund |
| 2023-12-11 | SymBio Pharmaceuticals Limited4582 | Position 1,200,000 shares | Ratio 2.92% | ▲0.26% | Evo Fund |
| 2023-12-01 | SymBio Pharmaceuticals Limited4582 | Position 1,092,700 shares | Ratio 2.66% | ▲0.22% | Evo Fund |
| 2023-11-30 | SymBio Pharmaceuticals Limited4582 | Position 1,004,100 shares | Ratio 2.44% | ▲0.25% | Evo Fund |
| 2023-11-29 | SymBio Pharmaceuticals Limited4582 | Position 899,100 shares | Ratio 2.19% | ▲0.17% | Evo Fund |
| 2023-11-28 | SymBio Pharmaceuticals Limited4582 | Position 831,600 shares | Ratio 2.02% | ▲0.35% | Evo Fund |
| 2023-11-27 | SymBio Pharmaceuticals Limited4582 | Position 687,500 shares | Ratio 1.67% | ▲0.32% | Evo Fund |
| 2023-11-24 | SymBio Pharmaceuticals Limited4582 | Position 553,100 shares | Ratio 1.35% | ▲0.23% | Evo Fund |
| 2023-11-22 | SymBio Pharmaceuticals Limited4582 | Position 459,900 shares | Ratio 1.12% | ▲0.25% | Evo Fund |
| 2023-11-21 | SymBio Pharmaceuticals Limited4582 | Position 357,000 shares | Ratio 0.87% | ▲0.29% | Evo Fund |
| 2023-11-20 | SymBio Pharmaceuticals Limited4582 | Position 237,800 shares | Ratio 0.58% | ▲0.31% | Evo Fund |
| 2023-11-10 | SymBio Pharmaceuticals Limited4582 | Position 0 shares | Ratio 0.00% | ▼3.01% | Evo Fund |
| 2023-11-07 | SymBio Pharmaceuticals Limited4582 | Position 1,200,000 shares | Ratio 3.01% | ▲0.02% | Evo Fund |
| 2023-11-06 | SymBio Pharmaceuticals Limited4582 | Position 1,190,000 shares | Ratio 2.99% | ▲0.17% | Evo Fund |
| 2023-10-24 | SymBio Pharmaceuticals Limited4582 | Position 1,124,800 shares | Ratio 2.82% | ▲0.35% | Evo Fund |
| 2023-10-23 | SymBio Pharmaceuticals Limited4582 | Position 983,800 shares | Ratio 2.47% | ▲0.26% | Evo Fund |
| 2023-10-20 | SymBio Pharmaceuticals Limited4582 | Position 880,900 shares | Ratio 2.21% | ▲0.19% | Evo Fund |
| 2023-10-19 | SymBio Pharmaceuticals Limited4582 | Position 805,200 shares | Ratio 2.02% | ▲0.28% | Evo Fund |
| 2023-10-18 | SymBio Pharmaceuticals Limited4582 | Position 694,000 shares | Ratio 1.74% | ▲0.25% | Evo Fund |
| 2023-10-17 | SymBio Pharmaceuticals Limited4582 | Position 593,200 shares | Ratio 1.49% | ▲0.32% | Evo Fund |
| 2023-10-16 | SymBio Pharmaceuticals Limited4582 | Position 464,800 shares | Ratio 1.17% | ▲0.28% | Evo Fund |
| 2023-10-13 | SymBio Pharmaceuticals Limited4582 | Position 355,500 shares | Ratio 0.89% | ▲0.27% | Evo Fund |
| 2023-10-12 | SymBio Pharmaceuticals Limited4582 | Position 245,400 shares | Ratio 0.62% | ▲0.33% | Evo Fund |
| 2021-04-09 | The Lead Co.,Inc.6982 | Position 0 shares | Ratio 0.00% | ▼0.65% | Evo Fund |
| 2021-04-08 | The Lead Co.,Inc.6982 | Position 17,000 shares | Ratio 0.65% | ▼0.11% | Evo Fund |
| 2021-04-07 | The Lead Co.,Inc.6982 | Position 20,000 shares | Ratio 0.76% | ▲0.76% | Evo Fund |
| 2020-12-25 | FUJITA CORPORATION Co.,Ltd.3370 | Position 0 shares | Ratio 0.00% | ▼0.91% | Evo Fund |
| 2020-12-24 | FUJITA CORPORATION Co.,Ltd.3370 | Position 17,500 shares | Ratio 0.91% | ▲0.91% | Evo Fund |
| 2020-05-15 | Kozosushi Co.,LTD.9973 | Position 0 shares | Ratio 0.00% | ▼1.65% | Evo Fund |
| 2020-05-14 | Kozosushi Co.,LTD.9973 | Position 1,693,100 shares | Ratio 1.65% | ▲1.00% | Evo Fund |
| 2020-05-13 | Kozosushi Co.,LTD.9973 | Position 669,900 shares | Ratio 0.65% | ▲0.19% | Evo Fund |
| 2020-01-30 | PIXELA CORPORATION6731 | Position 0 shares | Ratio 0.00% | ▼1.44% | Evo Fund |
| 2020-01-24 | PIXELA CORPORATION6731 | Position 1,000,000 shares | Ratio 1.44% | ▲0.09% | Evo Fund |
| 2020-01-23 | PIXELA CORPORATION6731 | Position 933,100 shares | Ratio 1.35% | ▲0.15% | Evo Fund |
| 2020-01-17 | PIXELA CORPORATION6731 | Position 828,800 shares | Ratio 1.20% | ▲0.19% | Evo Fund |
| 2020-01-15 | PIXELA CORPORATION6731 | Position 697,500 shares | Ratio 1.01% | ▲0.15% | Evo Fund |